Unlocking Hyperimmunes - Emerging Clinical Data about Cytogam, Presented by Kamada

Published 12 September 2024
  • Advanced Heart Failure & Transplantation
  • Advanced Lung Failure & Transplantation
  • Cardiothoracic Surgery
  • Industry
  • Mechanical Circulatory Support
  • News
  • Podcast
  • Publications & Journals
  • Pulmonary Vascular Disease (PAH & CTEPH)

 

In this episode of the ISHLT Voices podcast, hosted by Kamada, you’ll hear a discussion on the utilization of Cytomegalovirus Immune Globulin (CMV IgG) in solid organ transplantation (SOT) from the following speakers:


Martin Zamora Headshot
Martin Zamora, MD
Medical Director of Lung Transplantation 
Advent Health | Orlando, FL USA

 

 

 

Lorenzo Zaffiri Headshot
Lorenzo Zaffiri, MD, PhD
Medical Director of Lung Transplantation 
Emory University | Atlanta, GA USA

 

 

 

Robert Gottlieb Headshot
Robert Gottlieb, MD, PhD, FACC
Transplant Cardiologist 
Baylor Scott White | Dallas, TX USA

 

 

First, a focused overview of CMV IgG, including what they are, how they are made, and their role in SOT. The experts describe the differences between hyperimmune globulins like CMV IgG and standard immune globulins (IVIG). Then, enjoy a discussion from the experts on two recently presented poster highlighting CMV IgG use in lung transplantation and the need for new emerging data.

Listen Now

 

The content of this podcast was developed entirely by our industry partner, Kamada. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.


This episode was created for ISHLT Voices and sponsored by Kamada.

Logo for Kamada